An inter-ministerial committee has recommended classifying health supplements that claim to cure diseases as drugs. This move ...
In a letter to DCGI, industry body the Indian Pharmaceutical Alliance (IPA) says companies should be given 30 days’ notice to ...
A government panel in India is proposing stricter regulations on health claims made by supplement manufacturers. The panel ...
The additional recruitments will help the Drugs Controller General of India enforce good manufacturing practices for ...
This came after Zydus Healthcare presented the proposal for grant of permission for manufacturing and marketing of the drug ...
(Image Credits: Pixabay) The Central Drugs Standard Control Organisation (CDSCO) has flagged 49 commonly used medicines for failing quality tests in the latest monthly drug alert. In its monthly ...
New Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, ...
However, the required upgrades present significant technical and financial challenges for smaller manufacturers. Jatish Sheth ...
Experts said that besides large investments required to improve the manufacturing and testing facilities, the companies will ...
The Central Drug Standards Control Organisation (CDSCO) has flagged select batches of four drugs as spurious and listed 49 drugs and formulations as not of standard quality. The CDSCO found that ...
The Central Drugs Standard Control Organisation (CDSCO) has declared four samples of drugs drawn by drugs inspectors from various States and tested during the month of September, as spurious. The list ...
DCGI calls for meeting with stakeholders of cosmetics industry to discuss issues: Our Bureau, New Delhi Thursday, November 14, 2024, 08:00 Hrs [IST] The Drugs Controller General o ...